22nd Century - 15 Year Stock Split History | XXII

Stock split history for 22nd Century since 2011. Prices shown are actual historical values and are not adjusted for either splits or dividends. Please see the "Historical Prices" tab for adjusted price values.
Unlock Macrotrends Premium
40 years of data
Faster, ad-free pages
Unlimited data exports
Full-width charts
Sector Industry Market Cap Revenue
Consumer Staples Tobacco Products $0.001B $0.018B
22nd Century Group, Inc. is a plant biotechnology company focused on decreasing/increasing the level of nicotine in the tobacco plant through genetic engineering and breeding. The Company is focused on development of smoking cessation aid and owns and controls several patents. The company's products include X-22, a prescription smoking cessation aid, which is a tobacco-based botanical medical product for use as a smoking cessation therapy. 22nd Century Group, Inc. is based in Williamsville, New York.
Stock Name Country Market Cap PE Ratio
Philip Morris (PM) United States $293.986B 23.29
Altria (MO) United States $116.081B 12.53
British American Tobacco (BTI) United Kingdom $113.338B 0.00
JAPAN TOB (JAPAY) Japan $77.798B 24.08
Imperial Tobacco Group (IMBBY) United Kingdom $25.484B 0.00
Turning Point Brands (TPB) United States $1.320B 29.24
Universal (UVV) United States $1.099B 21.32
Air Global (AIIR) United States $0.297B 0.00
Ispire Technology (ISPR) United States $0.076B 0.00